NUVA on NASDAQ

NuVasive

Logo: Lifeofcheetah, CC BY-SA 4.0, via Wikimedia Commons4

American medical device company

NuVasive, Inc. is a medical devices company based in San Diego, California.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 18, 2026.

Overview

1997Founded1

Compare with Haemonetics, Embecta Corp. or AbioMed, or pick any stock.

  • TickerNUVA on NASDAQ1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersSan Diego1
  • Websitewww.nuvasive.com
  • Legal formDelaware corporation1
  • Incorporated inDE5
  • Business address7475 Lusk Blvd, San Diego, Ca 921215
  • Filer categoryLarge accelerated filer5

NuVasive, Inc. is a medical devices company based in San Diego, California. Founded in 1997, it primarily develops medical devices and procedures for minimally invasive spine surgery.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

72.0%Gross margin7
3.4%Net margin7
5.5%Revenue growth, 20227
4.7%Return on equity7
$29.9MFree cash flow7

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue28¢$336.5M
  • Selling, general and admin53¢$634.1M
  • Other costs15¢$179.0M
  • Income tax1¢$11.9M
  • Profit3¢$40.4M

Out of $1.2B in revenue.7

Where each dollar of operating cash went, fiscal 2022

  • Capital spending82¢$139.2M
  • Share buybacks3¢$5.7M
  • Kept or used elsewhere14¢$24.2M

Out of $169.1M of cash from operations.7

Financial statements

Revenue8910117$1.2B in 2022+25% since 2016
0$500.0M$1.0B$1.5B2016: $962.1M$962.1M20162017: $1.0B$1.0B2017+7%2018: $1.1B$1.1B2018+7%2019: $1.2B$1.2B2019+6%2020: $1.1B$1.1B2020−10%2021: $1.1B$1.1B2021+8%2022: $1.2B$1.2B2022+6%
Gross profit8910117$865.4M in 2022+20% since 2016
0$250.0M$500.0M$750.0M$1.0B2016: $722.0M$722.0M20162017: $758.2M$758.2M2017+5%2018: $790.6M$790.6M2018+4%2019: $855.7M$855.7M2019+8%2020: $729.0M$729.0M2020−15%2021: $816.7M$816.7M2021+12%2022: $865.4M$865.4M2022+6%
Net income8910117$40.4M in 2022+9% since 2016
-$100.0M-$50.0M0$50.0M$100.0M2016: $37.2M$37.2M20162017: $81.6M$81.6M2017+119%2018: $12.5M$12.5M2018−85%2019: $65.2M$65.2M2019+423%2020: -$37.2M-$37.2M20202021: -$64.1M-$64.1M2021+72%2022: $40.4M$40.4M2022
Fiscal year2016201720182019202020212022
Revenue$962.1M8$1.0B9$1.1B10$1.2B11$1.1B7$1.1B7$1.2B7
Cost of revenue$240.1M8$268.4M9$311.2M10$312.4M11$321.6M7$322.3M7$336.5M7
Gross profit$722.0M8$758.2M9$790.6M10$855.7M11$729.0M7$816.7M7$865.4M7
Research and development$48.0M8$50.4M9$61.7M10$72.4M11$79.8M11$92.6M11
Selling, general and admin$533.6M8$539.5M9$575.8M10$611.2M11$547.2M7$610.1M7$634.1M7
Income tax$29.3M8-$7.5M9-$3.8M10$15.3M11-$10.4M7$5.7M7$11.9M7
Net income$37.2M8$81.6M9$12.5M10$65.2M11-$37.2M7-$64.1M7$40.4M7
Earnings per share$0.748$1.609$0.2410$1.2611-$0.727-$1.247$0.787
Earnings per share (diluted)$0.698$1.489$0.2410$1.2311-$0.727-$1.247$0.767

Compare NuVasive with another company

The story

NuVasive incorporated on July 21, 1997, as a medical device company in San Diego, California. The NuVasive approach to Minimally Invasive Surgery (MIS) was a new surgical platform called Maximum Access Surgery (MAS). The flagship procedure is the XLIF (eXtreme Lateral Interbody Fusion) procedure, a minimally disruptive procedure that allows spine surgeons to have direct access to the intervertebral space from the side of the body, as opposed to the front or back. Their patient support division is called The Better Way Back.

NuVasive acquired the LessRay product from SafeRay Spine and launched the product in 2018 as a fluoroscopy system that enhances the clarity of radiographic images. They provide medical equipment, surgical support, and necessary funds to those in need of spine surgery around the world through the NuVasive Spine Foundation.

In May 2013, NuVasive acquired a small manufacturer, ANC LLC (located in Fairborn, Ohio) for $4.5 million. This decision to start making its own spinal-care devices eventually lead them to open a larger manufacturing facility in West Carrollton, Ohio. They fully moved all manufacturing to this larger facility in early 2018 employing roughly 300 by 2024. This new segment of Nuvasive, as an in-house parts maker called Nuvasive Manufacturing, LLC., is also known to keep a robust inventory of white boards in their effort to insource.

From Wikipedia’s article on NuVasive, shared under CC BY-SA 4.0.6

Leadership

Who has led NuVasive, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (44)

Products and brands

NuVasive has three business segments: Spine, Orthopedics (NuVasive Specialized Orthopedics), and Neuromonitoring (NuVasive Clinical Services).

From Wikipedia’s article on NuVasive, shared under CC BY-SA 4.0.6

Acquisitions

In 2016, Biotronic NeuroNetwork and Ellipse Technologies were acquired by NuVasive. In 2017, Vertera Spine and SafePassage were acquired by NuVasive. In 2021, NuVasive acquired Simplify Medical.

From Wikipedia’s article on NuVasive, shared under CC BY-SA 4.0.6

Timeline

  1. Feb 19, 2016New chief executive Edmund J. Roschak becomes CEO15
  2. May 28, 2015New chief executive Gregory T. Lucier becomes CEO16
  3. Jan 5, 2006New chief executive Alexis Lukianov V. becomes CEO17
  4. 1997Founded Founded1

Recent filings

  1. Sep 11, 202315-12G
  2. Sep 11, 2023SC 13G/A SCHEDULE 13G/A
  3. Sep 7, 2023SC 13G/A
  4. Sep 7, 2023EFFECT
  5. Sep 7, 2023EFFECT
  6. Sep 7, 2023EFFECT
  7. Sep 7, 2023EFFECT
  8. Sep 7, 2023EFFECT
  9. Sep 7, 2023EFFECT
  10. Sep 5, 20234 FORM 4 SUBMISSION
  11. Sep 5, 20234 FORM 4 SUBMISSION
  12. Sep 5, 20234 FORM 4 SUBMISSION
  13. Sep 5, 20234 FORM 4 SUBMISSION
  14. Sep 5, 20234 FORM 4 SUBMISSION
  15. Sep 5, 20234 FORM 4 SUBMISSION

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73